In our analysis of the genetic alterations of PHFs in breast cancer, we found that ZMYND8 had a higher frequency of amplification and overexpression in Luminal B breast cancer, and its overexpression was associated with shorter survival in patients in both TCGA and METABRIC datasets. Here, ZMYND8 is linked to breast cancer.